ATH 14.3% 0.3¢ alterity therapeutics limited

Ann: Appendix 4C and Quarterly Cash Flow Report, page-11

  1. 2,811 Posts.
    lightbulb Created with Sketch. 975
    Over 4 months are behind us from "the transformative year of 2022". Usually, Stamler has not been able to predict much more than a couple of weeks, if that. So I would not expect any transformative news during the last 3 months of 2022 he could predict today. So that gives us transformative months until the end of September, that is the next 4+ months.
    What could be the news to make 2022 a transformative year?
    - ph 2 study for MSA with ATH434 has really started with many patients.
    - ph 2 study for otitis media with PBT2 is accepted by authorities and money for the study has been found.
    - Early results of primate study of PD are published
    - preclinical studies about brain injuries and Alzheimer's will be published ( ATH434 or other iron chelators)

    Anything else ????
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.18K 3.279M

Buyers (Bids)

No. Vol. Price($)
38 52064257 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126697935 22
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.